Advertisement

Bone Lesions, X-Linked Hypophosphatemic (Hyp) Mouse

  • Ralph A. MeyerJr.
Part of the Monographs on Pathology of Laboratory Animals book series (LABORATORY)

Abstract

X-linked hypophosphatemia is a genetically dominant, metabolic bone disease that occurs in both humans and mice (Rasmussen and Anast 1983). The X-linked hypophosphatemic (Hyp) mouse is characterized by dwarfism, rickets, osteomalacia, and low plasma phosphate (Eicher et al. 1976; Meyer et al. 1979). There is a reduced renal tubular reabsorption of phosphate (Eicher et al. 1976) that accounts for the hypophosphatemia and is a major cause of the bone disease. There are abnormalities in the bone growth of the craniofacial region (Iorio et al. 1980). In Addition, synostosis of the cranial and facial sutures has been found in the skull (Roy et al 1981) (Figs. 341, 342).

Keywords

Hypophosphatemic Rickets Facial Suture Femoral Mineral Progressive Ankylosis Resistant Rickets 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bar-Shavit Z, Kahn AJ, Teitelbaum SL (1983) Defective binding of macrophages to bone in rodent osteo-malacia and vitamin D deficiency. In vitro evidence for a cellular defect and altered saccharides in the bone matrix. J Clin Invest 72: 526–534PubMedCrossRefGoogle Scholar
  2. Boneh A, Reade TM, Scriver CR, Rishikof E (1987) Audiometric evidence for two forms of X-linked hypophosphatemia in humans, apparent counterparts of Hyp and Gy mutations in mouse. Am J Med Genet 27: 997–1003PubMedCrossRefGoogle Scholar
  3. Brault BA, Meyer MH, Meyer RA Jr, Iorio RJ (1987) Mineral uptake by the femora of older female X- linked hypophosphatemic ( HYP) mice but not older male HYP mice. Clin Orthop 222: 289–299PubMedGoogle Scholar
  4. Cowgill LD, Goldfarb S, Lau K, Slatopolsky E, Agus ZS (1979) Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets. J Clin Invest 63: 1203–1210PubMedCrossRefGoogle Scholar
  5. Drezner MK, Lyles KW, Haussler MR, Harrelson JM (1980) Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X- linked hypophosphatemic rickets and osteomalacia. J Clin Invest 66: 1020–1032PubMedCrossRefGoogle Scholar
  6. Eicher EM, Southard JL, Scriver CR, Glorieux FH (1976) Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73: 4667–4671PubMedCrossRefGoogle Scholar
  7. Giasson SD, Brunette MG, Danan G, Vigneault N, Carriere S (1977) Micropuncture study of renal phosphorus transport in hypophosphatemic vitamin D resistant rickets in mice. Pflugers Arch 371: 33–38PubMedCrossRefGoogle Scholar
  8. Glorieux FH, Ecarot-Charrier B (1987) X-linked vitamin-D resistant rickets: is osteoblast activity defective? In: Cohn DV, Martin TJ, Meunier PJ (eds) Calcium regulation and bone metabolism: basic and clinical aspects, vol 9. Elsevier/North-Holland, New YorkGoogle Scholar
  9. Iorio RJ, Murray G, Meyer RA Jr (1980) Craniometric measurements of craniofacial malformations in mice with X-linked, dominant hypophosphatemia (vitamin D-resistant rickets). Teratology 22: 291–298PubMedCrossRefGoogle Scholar
  10. Kay MA, Meyer MH, Delzer PR, Meyer RA Jr (1985) Changing patterns of femoral and skeletal mineralization during growth in juvenile X-linked hypophosphatemic mice. Miner Electrolyte Metab 11: 374–380PubMedGoogle Scholar
  11. Kiebzak GM, Roos BA, Meyer RA Jr (1982) Secondary hyperparathyroidism in X-linked hypophosphatemic mice. Endocrinology 111: 650–652PubMedCrossRefGoogle Scholar
  12. Lobaugh B, Drezner MK (1983) Abnormal regulation of renal 25-hydroxyvitamin D-l alpha-hydroxylase activity in the X-linked hypophosphatemic mouse. J Clin Invest 71: 400–403PubMedCrossRefGoogle Scholar
  13. Lyon MF, Scriver CR, Baker LR, Tenenhouse HS, Kronick J, Mandla S (1986) The Gy mutation: another cause of X-linked hypophosphatemia in mouse. Proc Natl Acad Sci USA 83: 4899–4903PubMedCrossRefGoogle Scholar
  14. Marie PJ, Travers R (1983) Effects of magnesium and lactose supplementation on bone metabolism in the X-linked hypophosphatemic mouse. Metabolism 32: 165–171PubMedCrossRefGoogle Scholar
  15. Marie PJ, Travers R, Glorieux FH (1981) Healing of rickets with phosphate supplementation in the hypo-phosphatemic male mouse. J Clin Invest 67: 911–914PubMedCrossRefGoogle Scholar
  16. Meyer RA Jr, Jowsey J, Meyer MH (1979) Osteomalacia and altered magnesium metabolism in the X- linked hypophosphatemic mouse. Calcif Tissue Int 27: 19–26PubMedCrossRefGoogle Scholar
  17. Meyer RA Jr, Gray RW, Meyer MH (1980) Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology 107: 1577–1581PubMedCrossRefGoogle Scholar
  18. Meyer RA Jr, Meyer MH, Gray RW, Bruns ME (1987) Evidence that low plasma 1,25 dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice. J Bone Miner Res 2: 67–82PubMedCrossRefGoogle Scholar
  19. Mostafa YA, Meyer RA Jr (1981) Increased metaphyseal bone mass in the young X-linked hypophosphatemic ( Hyp) mouse. Clin Orthop 161: 326–335PubMedGoogle Scholar
  20. Mostafa YA, El-Mangoury NH, Meyer RA Jr, Iorio RJ (1982) Deficient nasal bone growth in the X-linked hypophosphataemic ( Hyp) mouse and its implication in craniofacial growth. Arch Oral Biol 27: 311–317PubMedCrossRefGoogle Scholar
  21. Rasmussen H, Anast C (1983) Familial hypophosphatemic rickets and vitamin D-dependent rickets. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 1743–1773Google Scholar
  22. Roy WA, Iorio RJ, Meyer GA (1981) Craniosynostosis in vitamin D-resistant rickets. A mouse model. J Neurosurg 55: 265–271PubMedCrossRefGoogle Scholar
  23. Sela J, Bab I, Deol MS (1982) Patterns of matrix vesicle calcification in osteomalacia of Gyro mice. Metab Bone Dis Relat Res 4: 129–134PubMedCrossRefGoogle Scholar
  24. Soener RA, Meyer MH, Meyer RA Jr (1988) Ovariectomy abolishes the normalization of femoral mineral content (g/cm) in 40 week old female X-linked hypophosphatemic mice. Miner Electrolyte Metab 14: 321–331PubMedGoogle Scholar
  25. Tenenhouse HS (1983) Abnormal renal mitochondrial 25-hydroxyvitamin D3-l-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse. Endocrinology 113: 816–818PubMedCrossRefGoogle Scholar
  26. Tenenhouse HS, Scriver CR, Mclnnes RR, Glorieux FH (1978) Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane. Kidney Int 14: 236–244PubMedCrossRefGoogle Scholar
  27. Vaughn LK, Meyer RA Jr, Meyer MH (1986) Increased metabolic rate in X-linked hypophosphatemic mice. Endocrinology 118: 441–445PubMedCrossRefGoogle Scholar
  28. Yamamoto T, Seino Y, Tanaka H, Yamaoka K, Kurose H, Ishida M, Yabuuchi H (1988) Effects of the administration of phosphate on nuclear 1-25-dihydroxyvitamin D3 uptake by duodenal mucosal cells of Hyp mice. Endocrinology 122: 576–580PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Ralph A. MeyerJr.

There are no affiliations available

Personalised recommendations